Pharmacokinetics and Inflammatory Fluid Penetration of Intravenous Daptomycin in Volunteers
AUTOR(ES)
Wise, R.
FONTE
American Society for Microbiology
RESUMO
The lipopeptide antimicrobial daptomycin was administered intravenously at a dose of 4 mg/kg of body weight to seven healthy male volunteers. The concentrations of daptomycin in plasma, cantharidin-induced inflammatory fluid, and urine were measured by a microbiological assay. The mean ± standard deviation peak concentrations in plasma and inflammatory fluid were 77.5 ± 8.3 and 27.6 ± 9.5 μg/ml, respectively; the mean terminal elimination half-lives were 7.74 and 13.2 h, respectively. The overall penetration of total drug into the inflammatory fluid (measured by ratio of the area under the concentration-time curve from 0 to 24 h for inflammatory fluid compared with that for plasma) was 68.4%. The mean urinary recovery over 24 h was 59.7%.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=126970Documentos Relacionados
- Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteers.
- Pharmacokinetics and Inflammatory-Fluid Penetration of Moxifloxacin following Oral or Intravenous Administration
- Pharmacokinetics and inflammatory fluid penetration of sparfloxacin.
- Pharmacokinetics and Inflammatory Fluid Penetration of Clinafloxacin
- Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).
